Ying J - Search Results

1

Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer.

Song P, Zhang F, Li Y, Yang G, Li W, Ying J, Gao S. Song P, et al. Among authors: ying j. Cancer Med. 2019 Apr;8(4):1551-1557. doi: 10.1002/cam4.2043. Epub 2019 Mar 7. Cancer Med. 2019. PMID: 30843662 Free PMC article.

2

Fhit protein expression in lung cancer studied by high-throughput tissue microarray.

Feng X, Li L, Gao Y, Zhang J, Ying J, Xiao T, Gao J, Liu X, Sun Y, Cheng S. Feng X, et al. Among authors: ying j. Bull Cancer. 2007 Mar;94(3):E8-11. Bull Cancer. 2007. PMID: 17371765

3

Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma.

Ying J, Guo L, Qiu T, Shan L, Ling Y, Liu X, Lu N. Ying J, et al. Ann Oncol. 2013 Oct;24(10):2589-2593. doi: 10.1093/annonc/mdt295. Epub 2013 Jul 31. Ann Oncol. 2013. PMID: 23904459 Free article.

4

Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement.

Shan L, Lian F, Guo L, Yang X, Ying J, Lin D. Shan L, et al. Among authors: ying j. Diagn Pathol. 2014 Jan 14;9:3. doi: 10.1186/1746-1596-9-3. Diagn Pathol. 2014. PMID: 24422905 Free PMC article.

5

Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer.

Li X, Sun L, Hou J, Gui M, Ying J, Zhao H, Lv N, Meng S. Li X, et al. Among authors: ying j. Int J Cancer. 2015 Aug 1;137(3):512-24. doi: 10.1002/ijc.29405. Epub 2015 Jan 8. Int J Cancer. 2015. PMID: 25546612

6

Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.

Zhu X, Shan L, Wang F, Wang J, Wang F, Shen G, Liu X, Wang B, Yuan Y, Ying J, Yang H. Zhu X, et al. Among authors: ying j. Breast Cancer Res Treat. 2015 Apr;150(3):479-86. doi: 10.1007/s10549-015-3338-y. Epub 2015 Mar 18. Breast Cancer Res Treat. 2015. PMID: 25783183

7

Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay.

Qiu T, Lu H, Guo L, Huang W, Ling Y, Shan L, Li W, Ying J, Lv N. Qiu T, et al. Among authors: ying j. Sci Rep. 2015 Mar 18;5:9211. doi: 10.1038/srep09211. Sci Rep. 2015. PMID: 25784606 Free PMC article.

8

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.

Li W, Qiu T, Zhi W, Shi S, Zou S, Ling Y, Shan L, Ying J, Lu N. Li W, et al. Among authors: ying j. BMC Cancer. 2015 May 1;15:340. doi: 10.1186/s12885-015-1345-3. BMC Cancer. 2015. PMID: 25929517 Free PMC article.

9

[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].

Zhang Z, Wu X, Ying J, Li J, Qiu T, Guo H, Zhao H, Shan L, Ling Y. Zhang Z, et al. Among authors: ying j. Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):199-205. doi: 10.3779/j.issn.1009-3419.2015.04.05. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25936883 Free PMC article. Chinese.

10

BIRC6-ALK, a Novel Fusion Gene in ALK Break-Apart FISH-Negative Lung Adenocarcinoma, Responds to Crizotinib.

Shan L, Jiang P, Xu F, Zhang W, Guo L, Wu J, Zeng Y, Jiao Y, Ying J. Shan L, et al. Among authors: ying j. J Thorac Oncol. 2015 Jun;10(6):e37-9. doi: 10.1097/JTO.0000000000000467. J Thorac Oncol. 2015. PMID: 26001147 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,170 results

Search Page

Filters